Sangamo Therapeutics
SGMO
#8725
Rank
C$0.23 B
Marketcap
C$0.69
Share price
-6.45%
Change (1 day)
-75.20%
Change (1 year)

Market capitalization of Sangamo Therapeutics (SGMO)

Market cap: C$0.23 Billion

As of December 2025 Sangamo Therapeutics has a market cap of C$0.23 Billion. This makes Sangamo Therapeutics the world's 8725th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sangamo Therapeutics from 2000 to 2025

End of year Market Cap

Year Marketcap Change
2025C$0.23 B-69.92%
2024C$0.76 B499.76%
2023C$0.12 B-81.7%
2022C$0.69 B-49.85%
2021C$1.39 B-50.52%
2020C$2.81 B121.99%
2019C$1.26 B-20.67%
2018C$1.59 B-8.3%
2017C$1.74 B502.04%
2016C$0.28 B-67.51%
2015C$0.89 B-26.9%
2014C$1.21 B32.45%
2013C$0.92 B190.24%
2012C$0.31 B109.19%
2011C$0.15 B-49.67%
2010C$0.30 B7.46%
2009C$0.28 B61.63%
2008C$0.17 B-66.89%
2007C$0.52 B94.46%
2006C$0.26 B87.75%
2005C$0.14 B-21.24%
2004C$0.18 B2.85%
2003C$0.17 B50.55%
2002C$0.11 B-67.71%
2001C$0.36 B-43.7%
2000C$0.64 B

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of Sangamo Therapeutics was reported to be:

C$0.23 Billion
by Nasdaq info icon info icon
C$0.23 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
C$207.79 B 90,037.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$83.61 B 36,170.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$245.40 B 106,355.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$36.74 B 15,839.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
C$22.54 B 9,679.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$672.11 B 291,453.85%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$14.17 B 6,047.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$344.10 B 149,167.40%๐Ÿ‡บ๐Ÿ‡ธ USA